BTSG BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.…
Industry Peers
Health Information ServicesKey Statistics
About BrightSpring Health Services (NASDAQ: BTSG)
›
BrightSpring Health Services (NASDAQ: BTSG) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 23,500 employees.
The shares were at 64.02 USD on 19 November 2026, up 96.4% over 52 weeks. Its 52-week range is 30.64 USD to 73.75 USD: the price is 13.2% below the high and 108.9% above the low.
At a market capitalisation of 12.74B USD, it trades at 45.4 times trailing earnings and 26.4 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 40.2, a premium of 13% for BTSG.
BrightSpring Health Services reports return on equity of 10.2%, an operating margin of 3.5% and revenue up 26.4% year over year.
Its debt exceeds its cash by 1.66B USD, a debt-to-equity ratio of 1.44. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 17 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 83.44 USD is 30.3% above the current price. The next earnings report is expected on 26 February 2027.